Infectious Dis. Medical News about Bacteremia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bacteremia in febrile nonneutropenic pediatric oncology patients
Pediatric Blood & Cancer, 10/14/09

Kelly MJ et al. – Bacteremia is an important issue in febrile nonneutropenic pediatric oncology patients occurring in 6% of the patient visits in this study. The overall sensitivity of high–risk bacteremia to ceftriaxone provides justification for its empiric use in outpatient febrile nonneutropenic pediatric oncology patients.

Exclusive Author Commentary
Michael J. Kelly , 10/15/09

Nonneutropenic fever is a rather common clinical scenario in pediatric oncology. However, there have been few studies to guide management. This study demonstrates that bacteremia is not uncommon in this population and that these patients become bacteremic with a variety of both gram positive and gram negative organisms. It is encouraging that almost all of the high-risk organisms had at least an intermediate sensitivity to ceftriaxone, a common empiric antitibiotic choice in this scenario. Also, patients with external central lines (Broviacs or Hickmans) had a higher odds of having bacteremia compared to patients with ports. None of the patients with a source for fever on exam were bacteremic. This paper should help guide pediatric oncologists in managing this common clinical problem.

<< Previous
Does BCG vaccination protect against the development of childhood...

Next >>
Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact...